跳至主要内容
临床试验/DRKS00023562
DRKS00023562已完成4 期

Evaluation of the effectiveness of transcorneal electrostimulation in patients with retinitis pigmentosa - a multicenter, prospective, randomized, controlled and double-blind study on behalf of the G-BA - TES-RP

niversitätsklinikum Tübingen0 个研究点目标入组 141 人开始时间: 2021年2月18日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
141

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1. patients with syndromal or non-syndromal RP (autosomal dominant, auto-somal recessive and X-linked)
  • 2. adults of all sexes aged 18 - 80 years
  • 3. BCVA (ETDRS visual acuity) between 0.1 and 0.8 in both eyes with no more than 15 ETDRS letters (3 lines) difference between eyes
  • 4. octopus 900, kinetic visual field
  • a. Visual field area equal to or greater than 75 deg2 (corresponding to an average radius of 5 degrees; stimulus V4e) in both eyes.
  • b. The difference between the two eyes must have a ratio OD/OS not less than 0.5 and not more than 2
  • 5. able and willing to give written informed consent for the study

排除标准

  • Ophthalmic exclusion criteria:
  • 1. optic neuritis / optical neuropathy.
  • 2. diabetic retinopathy
  • 3. neovascularization of the retina of different genesis
  • 4. condition after retinal artery or vein occlusion
  • 5. condition after retinal detachment or vitreoretinal surgery
  • 6. silicone oil tamponade
  • 7. dry or neovascular AMD
  • 8. macular edema (SD-OCT)
  • 9. glaucoma
  • 10. corneal degeneration affecting visual acuity
  • 11. opacity of refractive media affecting OCT/FP/ophthalmoscopy (lens classification).
  • 12. cataract which, in the opinion of the investigator, may require surgery during the study period
  • 13. aphakia
  • 14. TES therapy in the last 3 months
  • Further exclusion criteria
  • 15. any chronic, non-controllable or unmanaged disease, e.g., but not limited to, cardiac or pulmonary disease, which increases the patient's risk during study participation
  • 16. poor general health that, in the opinion of the investigator, makes it difficult for the patient to reliably participate in visit appointments or to complete therapy
  • 17. mental illnesses such as bipolar disorder, schizo-affective disorder, addictions or dementia
  • 18. neurological diseases such as epilepsy or Parkinson's disease, which may pose a problem for the application of the therapy
  • 19. concurrent participation in other intervention studies or history of study participation, the effects of which may be ongoing
  • 20. active implants (except cochlear implants in a deactivated state)
  • 21. pregnancy or childbearing women of childbearing potential or lactation
  • 22. basic concerns of the investigator that the patient is capable and fit to participate.
  • 23. allergies to the materials used in the TES.

研究者

发起方
niversitätsklinikum Tübingen

相似试验